CLINICAL_TRIALS
trial_result
· 2021-01-15
Clinical Trial Update: Effect of Baricitinib Treatment on Peripheral Bone in RA [Phase 3]
Summary
Phase 3 trial investigating the effect of baricitinib on peripheral bone in rheumatoid arthritis patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Rheumatoid Arthritis, Bone Density | Phase 3 | Status: UNKNOWN